Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2026-03-07 @ 11:47 PM
Study NCT ID:
NCT02666950
Status:
COMPLETED
Last Update Posted:
2019-09-06
First Post:
2016-01-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
Sponsor:
Mayo Clinic
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Myelomonocytic Leukemia | View |
| None | Myelodysplastic Syndrome With Isolated Del(5q) | View |
| None | Myelodysplastic/Myeloproliferative Neoplasm | View |
| None | Previously Treated Myelodysplastic Syndrome | View |
| None | Recurrent Adult Acute Myeloid Leukemia | View |
| None | Untreated Adult Acute Myeloid Leukemia | View |
Keywords: